Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.

Aimoto M, Yamane T, Shiomoto K, Sakamoto C, Nakashima Y, Koh H, Nakane T, Takeoka Y, Hirose A, Nakamae M, Hagihara K, Terada Y, Nakao Y, Nakamae H, Hino M, Miyata S.

Int J Hematol. 2013 Oct;98(4):472-7.

PMID:
24022238
2.

IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.

Schenk S, El-Banayosy A, Morshuis M, Arusoglu L, Eichler P, Lubenow N, Tenderich G, Koerfer R, Greinacher A, Prohaska W.

J Thromb Haemost. 2007 Feb;5(2):235-41. Epub 2006 Oct 31.

3.

The level of heparin-induced antibodies in correlation with the result of the flow cytometric functional assay in the patients with suspected HIT.

Maličev E, Maček Kvanka M, Klemenc P, Rožman P.

J Clin Pathol. 2017 Dec;70(12):1084-1087. doi: 10.1136/jclinpath-2017-204498. Epub 2017 Sep 13.

PMID:
28903994
5.

Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.

Nazi I, Arnold DM, Warkentin TE, Smith JW, Staibano P, Kelton JG.

J Thromb Haemost. 2015 Oct;13(10):1900-7. doi: 10.1111/jth.13066. Epub 2015 Aug 29.

6.

Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.

Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D.

Br J Haematol. 1996 Mar;92(4):954-9.

PMID:
8616093
7.

Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.

Pearson MA, Nadeau C, Blais N.

Clin Appl Thromb Hemost. 2014 May;20(4):349-54. doi: 10.1177/1076029613513319. Epub 2013 Nov 27.

PMID:
24288385
8.

Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay.

Althaus K, Strobel U, Warkentin TE, Greinacher A.

Thromb Res. 2011 Sep;128(3):256-60. doi: 10.1016/j.thromres.2011.05.003. Epub 2011 May 28.

PMID:
21620439
9.

Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study.

Levine RL, Hergenroeder GW, Francis JL, Miller CC, Hursting MJ.

J Thromb Thrombolysis. 2010 Aug;30(2):142-8. doi: 10.1007/s11239-009-0425-0.

PMID:
19911252
10.

Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.

Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C.

Thromb Haemost. 1994 Feb;71(2):247-51.

PMID:
8191407
11.

Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.

Bakchoul T, Assfalg V, Zöllner H, Evert M, Novotny A, Matevossian E, Friess H, Hartmann D, Hron G, Althaus K, Greinacher A, Hüser N.

J Thromb Haemost. 2014 Jun;12(6):871-8. doi: 10.1111/jth.12569.

12.
13.

A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.

Demma LJ, Winkler AM, Levy JH.

Anesth Analg. 2011 Oct;113(4):697-702. doi: 10.1213/ANE.0b013e3182297031. Epub 2011 Jul 25.

PMID:
21788317
14.

Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.

Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lämmle B.

Am J Med. 2003 May;114(7):528-36.

PMID:
12753876
16.

Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.

Nellen V, Sulzer I, Barizzi G, Lämmle B, Alberio L.

Haematologica. 2012 Jan;97(1):89-97. doi: 10.3324/haematol.2011.048074. Epub 2011 Sep 20.

17.

Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study.

Lasocki S, Piednoir P, Ajzenberg N, Geffroy A, Benbara A, Montravers P.

Crit Care. 2008;12(3):R84. doi: 10.1186/cc6937. Epub 2008 Jun 25.

18.

Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.

Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE.

J Thromb Haemost. 2007 Aug;5(8):1666-73. Epub 2007 May 7.

19.

Supplemental Content

Support Center